According to Dr. Laudenslager and Hall, taking GLP1-s can indeed decrease bone density for some people. But that’s likely due ...

Fatty liver disease has become one of the most common liver conditions globally, closely tied to rising rates of obesity and metabolic disorders. Often described as a silent disease, it can progress ...

The disturbing statistics on childhood obesity in New Mexico should serve as a wake-up call to unite parents, public health experts, educators, doctors, lawmakers and farmers in a coordinated effort ...